Fabbrica Italiana Sintetici
Corporate brand
UnclaimedFabbrica Italiana Sintetici (FIS) is an Italian CDMO leader for small molecule APIs and intermediates, with three integrated manufacturing plants in Italy and commercial offices in North America and Japan.
Last updated September 16, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Fabbrica Italiana Sintetici (FIS) is a contract development and manufacturing organization (CDMO) and supplier of active pharmaceutical ingredients (APIs). According to its official website, FIS is one of the CDMO leaders for small molecule APIs and intermediates, supporting partners across the entire cycle from synthetic process optimization and scale-up to large-scale production. Alongside its CDMO business, FIS supplies high-quality active pharmaceutical ingredients to manufacturers worldwide through a well-established generics portfolio. The company operates globally with three fully integrated manufacturing plants in Italy, commercial offices in North America and Japan, and an operational presence in India and China. Its Italian sites include Montecchio Maggiore (HQ and production site), Lonigo (production site), Termoli (production site), and Vicenza (La Vela offices). FIS states it has 70 years of expertise and describes its three plants as strongly interconnected, offering a versatile capacity range from 10 L to 18,000 L and over 3,000 m³ of total reactor capacity.
History
Fabbrica Italiana Sintetici (FIS) describes itself as having 70 years of expertise. It has evolved into a CDMO and API supplier, covering the entire development cycle from synthesis process optimization and scale-up to large-scale production. Its three Italian plants, located in close geographical proximity, are strongly interconnected and united by a shared legacy, forming a fully integrated network with a versatile capacity range from 10 L to 18,000 L. FIS operates globally with three fully integrated manufacturing plants in Italy, commercial offices in North America and Japan, and an operational presence in India and China.
Products and positioning
CDMO leader for small molecule APIs and intermediates; trusted partner to the global pharmaceutical industry.
Small molecule APIs & Intermediates
FIS is one of the CDMO leaders for small molecule APIs & Intermediates, driving innovation in drug development and production.
Generics portfolio
Alongside its CDMO business, FIS supplies high-quality active pharmaceutical ingredients to manufacturers worldwide through a well-established generics portfolio.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/fabbrica-italiana-sintetici · Editorial policy · How profiles are compiled